Pacific BioLabs (PBL) is pleased to announce the launch of In Vitro Sciences offering in vitro, cell-based assays supporting the pharmaceutical, biopharma, and medical device industries. The addition of this group to the PBL testing portfolio increases upon and is complimentary to well-established testing capabilities in our Microbiology, Analytical/Bioanalytical, and In Vivo departments.
Cell-based assays fall into several categories and are often used as tools to explore initial biological responses to a variety of stimuli. For example, the biopharmaceutical industry may utilize cell-based assays at early stages of product development in establishing product safety/potency whereas the medical device industry may use the same assays to evaluate the cytotoxic potential of leachable/extractable materials in a new device proposed for human use. Further, industry-based initiatives are underway to transition from traditional high-dose animal studies to an approach that is based on an understanding of cellular responses using well-designed in vitro, cell-based assays.
The In Vitro Sciences group is led by highly experienced scientists with a depth of subject matter expertise that enables characterization of an array of biological activities utilizing both stand alone and integrated assay endpoints/readouts. Contact PBL to discuss your in-vitro, cell-based assay needs.
- Cell Bank and Cell Culture Core – Primary and Immortalized Cell Lines
- Cytotoxicity Assays
- Proliferation Assays
- Apoptosis Assays
- Hemolysis Assays
- Angiogenesis Assays
- Reporter Assays
- Cytokine Release Assays
- Ex Vivo Animal Primary Cells
- Custom Method Development and Transfer
- Animal Model Alternatives